Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swathi Chinaranagari

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Cancer Research|January 26, 2016
Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cellsDivya Patel, Swathi Chinaranagari, Jaideep Chaudhary
Oncotarget|August 14, 2014
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancerSwathi Chinaranagari, Pankaj Sharma, Jaideep Chaudhary
Biochimie|March 18, 2015
Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activityPankaj Sharma, Swathi Chinaranagari, Jaideep Chaudhary
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Prostate cancer epigenomeSwathi Chinaranagari, Pankaj Sharma, Nathan J Bowen, et al.
Anticancer Research|October 15, 2013
Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cellsJason P Carey, Ashley Evans Knowell, Swathi Chinaranagari, et al.
Cancer Medicine|January 24, 2013
Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancerPankaj Sharma, Swathi Chinaranagari, Divya Patel, et al.
Molecular Cancer|June 22, 2013
Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTENPankaj Sharma, Ashley Evans Knowell, Swathi Chinaranagari, et al.
Molecular Endocrinology (Baltimore, Md.)|June 13, 2014
Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancerDivya Patel, Ashley E Knowell, Maxwell Korang-Yeboah, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Cancer Research|January 26, 2016
Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cellsDivya Patel, Swathi Chinaranagari, Jaideep Chaudhary
Oncotarget|August 14, 2014
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancerSwathi Chinaranagari, Pankaj Sharma, Jaideep Chaudhary
Biochimie|March 18, 2015
Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activityPankaj Sharma, Swathi Chinaranagari, Jaideep Chaudhary
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Prostate cancer epigenomeSwathi Chinaranagari, Pankaj Sharma, Nathan J Bowen, et al.
Anticancer Research|October 15, 2013
Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cellsJason P Carey, Ashley Evans Knowell, Swathi Chinaranagari, et al.
Cancer Medicine|January 24, 2013
Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancerPankaj Sharma, Swathi Chinaranagari, Divya Patel, et al.
Molecular Cancer|June 22, 2013
Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTENPankaj Sharma, Ashley Evans Knowell, Swathi Chinaranagari, et al.
Molecular Endocrinology (Baltimore, Md.)|June 13, 2014
Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancerDivya Patel, Ashley E Knowell, Maxwell Korang-Yeboah, et al.
Pageof 1